CompletedNot Applicable

Capsule Endoscopy vs Standard of Care for Obscure Intestinal Bleeding

Canada160 participantsStarted 2007-02

Plain-language summary

The role of capsule endoscopy (CE) in patients with obscure / occult gastrointestinal (GI) bleeding remains unclear. This pragmatic randomized controlled trial is designed to determine the diagnostic yield and clinical outcomes of patients with obscure GI bleeding who receive CE compared to those who receive usual standard care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients age over 18years with iron deficiency anemia (IDA). IDA is defined as hemoglobin \<137g/L in men or \<120g/L in women with serum ferritin level \<22ug/L in men and \<10ug/L in women.
✓. Eligible patients should have a negative gastroscopy and negative colonoscopy within 1 year prior to entry into study.
✓. Negative celiac screen and /or negative small bowel biopsies

Exclusion criteria

✕. Overt gastrointestinal bleeding
✕. Premenopausal women with menorrhagia
✕. Known or suspected small bowel obstruction
✕. Serious medical co-morbidities precluding surgery given the risk of capsule impaction
✕. Pregnancy
✕. Inability to provide informed consent

What they're measuring

diagnostic yield

Timeframe: 48 weeks

Trial details

NCT IDNCT00694954

SponsorUniversity of Calgary

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Iron Deficiency Anemia trials